EV Biologics (EV Biologics) Other Current Liabilities : $-4.37 Mil (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Other Current Liabilities?

EV Biologics's other current liabilities for the quarter that ended in Dec. 2017 was $-4.37 Mil.

EV Biologics's quarterly other current liabilities declined from Dec. 2016 ($0.01 Mil) to Jun. 2017 ($0.00 Mil) and declined from Jun. 2017 ($0.00 Mil) to Dec. 2017 ($-4.37 Mil).

EV Biologics's annual other current liabilities increased from Jun. 2015 ($0.00 Mil) to Jun. 2016 ($0.07 Mil) but then declined from Jun. 2016 ($0.07 Mil) to Jun. 2017 ($0.00 Mil).

EV Biologics Other Current Liabilities Historical Data

The historical data trend for EV Biologics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Other Current Liabilities Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Other Current Liabilities

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Other Current Liabilities	Get a 7-Day Free Trial												-	-	-	-	-

EV Biologics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

EV Biologics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of EV Biologics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Other Current Liabilities

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3